Axillary lymph-node metastases as the primary presentation of high-grade serous ovarian carcinoma: A case report.

axillary lymph‐node metastases cancer of unknown primary carcinoma of unknown primary high‐grade serous ovarian carcinoma

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 07 12 2021
revised: 10 03 2022
accepted: 28 03 2022
entrez: 20 4 2022
pubmed: 21 4 2022
medline: 21 4 2022
Statut: epublish

Résumé

We reported a female presented with an initial diagnosis of metastatic axillary lymph-node carcinoma that comprehensive assessments revealed a definitive diagnosis of high-grade serous ovarian carcinoma as the primary tumor.

Identifiants

pubmed: 35441016
doi: 10.1002/ccr3.5724
pii: CCR35724
pmc: PMC9010726
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e05724

Informations de copyright

© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Horm Mol Biol Clin Investig. 2019 Aug 9;41(3):
pubmed: 31398143
Clin Case Rep. 2022 Apr 14;10(4):e05724
pubmed: 35441016
Front Oncol. 2021 Apr 19;11:658636
pubmed: 33954114
Breast Cancer Res Treat. 2010 Jan;119(1):1-11
pubmed: 19771506
Future Oncol. 2020 Mar;16(7):225-246
pubmed: 31746224
Obstet Gynecol. 2001 Aug;98(2):212-7
pubmed: 11506835
J Ovarian Res. 2014 Feb 10;7:20
pubmed: 24506831
J Natl Compr Canc Netw. 2021 Feb 02;19(2):191-226
pubmed: 33545690
Am J Surg Pathol. 2014 Jan;38(1):13-22
pubmed: 24145643
Int J Gynecol Cancer. 2019 Feb;29(2):377-381
pubmed: 30718316
Gynecol Oncol. 2018 Sep;150(3):460-465
pubmed: 30001833
Acta Oncol. 2018 Mar;57(3):331-337
pubmed: 29130381
Eur J Gynaecol Oncol. 2011;32(2):237-9
pubmed: 21614929
JAMA. 1993 Mar 3;269(9):1119-22
pubmed: 8433466
Lancet. 2012 Apr 14;379(9824):1428-35
pubmed: 22414598
Cancer Rep (Hoboken). 2021 Jun 5;:e1463
pubmed: 34089302
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Cell Biochem. 2018 Oct 28;:
pubmed: 30368889
Eur J Cancer. 2003 Sep;39(14):1990-2005
pubmed: 12957453
Adv Anat Pathol. 2019 Sep;26(5):329-339
pubmed: 31368906
J Cell Physiol. 2019 Apr;234(4):4191-4199
pubmed: 30362518
Curr Pharm Des. 2018;24(39):4646-4651
pubmed: 30636576
Gynecol Oncol. 2012 Jul;126(1):64-8
pubmed: 22542580

Auteurs

Monire Mirzaei (M)

Clinical Research Development Center Nekouei-Forghani Hospital Qom University of Medical Sciences Qom Iran.

Abbas Eshraghi (A)

Clinical Research Development Center Qom University of Medical Sciences Qom Iran.

Mahdiieh Ghoddoosi (M)

Department of Pathology Shahid Beheshti Hospital Qom University of Medical Sciences Qom Iran.

Maedeh Alsadat Fatemi (MA)

Cancer Research Center Babol University of Medical Sciences Babol Iran.

Azhar Eshraghi (A)

Qom University of Medical Sciences Qom Iran.

Sara Shenavaei (S)

Student Research Committee Mashhad University of Medical Sciences Mashhad Iran.

Danial Fazilat-Panah (D)

Cancer Research Center Babol University of Medical Sciences Babol Iran.

Classifications MeSH